摘要
目的观察康柏西普眼用注射液单次玻璃体腔注射治疗视网膜静脉阻塞伴有黄斑水肿的短期疗效。方法观察自2014年12月至2015年9月期间在安徽省立医院诊断为视网膜静脉阻塞合并黄斑水肿病例14例(14只眼)。诊断明确后行玻璃体腔注射0.05ml康柏西普眼用注射液,治疗后随访4周,复诊观察最佳矫正视力、黄斑中心凹厚度。结果康柏西普治玻璃体腔单次注射后4周复诊最佳矫正视力与治疗前相比,视力提高(t=8.23,P<0.05),黄斑中心凹厚度降低(t=11.24,P<0.05),差异均有统计学意义。结论康柏西普单次玻璃体腔注射治疗视网膜静脉阻塞伴有黄斑水肿短期内安全有效。
Objetive To evaluate the efficiency of conbercept intravitreal injection in patients with macular edema caused by retinal vein occlusion（RVO）. Methods 14 eyes of 14 patients with macular edema caused by RVO were included. The patients were treated with 0.05 ml intravitreal injection of conbercept just once and followed up for 4 weeks. Best corrected visual acuity and central subfield thickness were analyzed. Results Four weeks after the administration of conbercept, we found in our patients that best corrected visual acuity improved（t=8.23,P 0.05）and central subfield thickness decreased（t=11.24,P 0.05）. Conclusion Conbercept intravitreal injection is efficient for treating RVO complicated with macular edema.
出处
《实用防盲技术》
2016年第2期69-71,共3页
Journal of Practical Preventing Blind
关键词
康柏西普
视网膜静脉阻塞
黄斑水肿
Conbercept
Branch retinal vein occlusion
Macular edema
